Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (1R43AI129444-01A1)
Received: 23 April 2020
Accepted: 28 July 2020
First Online: 5 August 2020
Ethics approval and consent to participate
: The activities performed in this study were determined not to constitute human subjects research by Pearl IRB (IRB Study Number: 18-OSSI-102).
: Not applicable.
: EJ.W., A.M.S., and B.H.J. are employed by and have ownership interest in Ossium Health, Inc. J.R.W. and J.W.H. are consultants to Ossium Health, Inc., G.B. has an ownership interest in Ossium Health, Inc.